GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » CK Life Sciences International Holdings Inc (FRA:LSI) » Definitions » Cyclically Adjusted Price-to-FCF

CK Life Sciences International Holdings (FRA:LSI) Cyclically Adjusted Price-to-FCF : (As of Jun. 05, 2024)


View and export this data going back to . Start your Free Trial

What is CK Life Sciences International Holdings Cyclically Adjusted Price-to-FCF?

Shiller PE for Stocks: The True Measure of Stock Valuation


CK Life Sciences International Holdings Cyclically Adjusted Price-to-FCF Historical Data

The historical data trend for CK Life Sciences International Holdings's Cyclically Adjusted Price-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CK Life Sciences International Holdings Cyclically Adjusted Price-to-FCF Chart

CK Life Sciences International Holdings Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted Price-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only 68.25 64.93 45.14 57.72 41.11

CK Life Sciences International Holdings Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Cyclically Adjusted Price-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 45.14 - 57.72 - 41.11

Competitive Comparison of CK Life Sciences International Holdings's Cyclically Adjusted Price-to-FCF

For the Biotechnology subindustry, CK Life Sciences International Holdings's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


CK Life Sciences International Holdings's Cyclically Adjusted Price-to-FCF Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, CK Life Sciences International Holdings's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where CK Life Sciences International Holdings's Cyclically Adjusted Price-to-FCF falls into.



CK Life Sciences International Holdings Cyclically Adjusted Price-to-FCF Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted Price-to-FCF takes the Free Cash Flow per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/FCF calculation. Because it considers this 10-year average, it's often referred to as the CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF.

CK Life Sciences International Holdings's Cyclically Adjusted FCF per Share for the fiscal year that ended in Dec23 is calculated as:

For example, CK Life Sciences International Holdings's adjusted Free Cash Flow per Share data for the fiscal year that ended in Dec23 was:

Adj_FreeCashFlowPerShare=Free Cash Flow per Share/CPI of Dec23 (Change)*Current CPI (Dec23)
=0.003/117.2957*117.2957
=0.003

Current CPI (Dec23) = 117.2957.

CK Life Sciences International Holdings Annual Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201412 0.002 99.707 0.002
201512 0.001 102.015 0.001
201612 0.003 103.225 0.003
201712 0.000 104.984 0.000
201812 -0.001 107.622 -0.001
201912 0.002 110.700 0.002
202012 0.002 109.711 0.002
202112 0.002 112.349 0.002
202212 0.002 114.548 0.002
202312 0.003 117.296 0.003

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


CK Life Sciences International Holdings  (FRA:LSI) Cyclically Adjusted Price-to-FCF Explanation

Compared with the regular Price-to-Free-Cash-Flow, which works poorly for cyclical businesses, the Cyclically Adjusted Price-to-FCF smoothed out the fluctuations of free cash flow during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted Price-to-FCF should give similar results to regular Price-to-Free-Cash-Flow.


CK Life Sciences International Holdings Cyclically Adjusted Price-to-FCF Related Terms

Thank you for viewing the detailed overview of CK Life Sciences International Holdings's Cyclically Adjusted Price-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


CK Life Sciences International Holdings (FRA:LSI) Business Description

Traded in Other Exchanges
Address
2 Dai Fu Street, Tai Po Industrial Estate, Tai Po, Hong Kong, HKG
CK Life Sciences International Holdings Inc is a biotechnology company engaged in the research & development, commercialization, and sale of health and agricultural-related products. Products developed by CK Life Sciences are categorized into the areas of human health and environmental sustainability. The company operates three core businesses, including agriculture, nutraceutical, and pharmaceutical. Its overall product portfolio involves a presence that spans North America and the Asia Pacific. The company uses mergers and acquisitions when it identifies attractive market opportunities.

CK Life Sciences International Holdings (FRA:LSI) Headlines